Metraipolis › archive › dc_e283948dd2a4

Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating Agents — Europe PMC PMID:41159383

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41159383
DOI
10.1111/ejh.70058
License (as archived)
solo-consultazione
Archived
2026-11-08T23:28:11.683Z
SHA-256 of the archived text
69fa5ef01a3a779b92e5ae90cead9ab294cc1c750d32dcbcf9c77efa28416cfd
Stable URL of this page
https://metraipolis.com/documento/dc_e283948dd2a4

How to cite

Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating Agents — Europe PMC PMID:41159383 — Europe PMC (en), https://europepmc.org/article/MED/41159383 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e283948dd2a4 (Metraipolis archive dc_e283948dd2a4, sha256 69fa5ef01a3a779b92e5ae90cead9ab294cc1c750d32dcbcf9c77efa28416cfd)
BibTeX
@misc{dce283948dd2a4,
  title = {Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating Agents — Europe PMC PMID:41159383},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41159383},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e283948dd2a4; sha256 69fa5ef01a3a779b92e5ae90cead9ab294cc1c750d32dcbcf9c77efa28416cfd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41159383. Agents can read the archived copy with the MCP tool read_document.